Surgery Partners, Inc. (SGRY) Misses Q3 EPS by 6c; reaffirms guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- US stocks set for higher open as AI trade steadies; midterms in focus
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 6% as Iran signals openness to peace talks
- Why has the market become so unforgiving of AI earnings?
- EchoStar rises on report SpaceX in talks to buy Boost Mobile or tap its network
Tweet
Share
E-mailGet Alerts SGRY Hot Sheet
Join SI Premium – FREE
Surgery Partners, Inc. (NASDAQ: SGRY) reported Q3 EPS of $0.19, $0.06 worse than the analyst estimate of $0.25. Revenue for the quarter came in at $770.4 million versus the consensus estimate of $768.99 million.
GUIDANCE:
Surgery Partners, Inc. sees FY2024 revenue of $3.075 billion, versus the consensus of $3.086 billion.
For earnings history and earnings-related data on Surgery Partners, Inc. (SGRY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Anthropic PBC: adjusted operating income increased for the three months ended September 30, 2026 to $2.5 billion
- Oshkosh (OSK) PT Lowered to $164 at DA Davidson
- Eli Lilly (LLY) PT Raised to $1,600 at Cantor Fitzgerald
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
